By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Eiger Biopharma 



Palo Alto  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS



Segment
Start Up





Company News
Eiger Biopharma Announces Interim Results Of Lonafarnib In Combination With Ritonavir Or Pegylated Interferon In Patients Infected With Hepatitis Delta Virus (HDV) 4/27/2015 8:14:32 AM
FDA Grants Fast Track Designation To Eiger Biopharma's Lonafarnib For Hepatitis Delta Virus (HDV) Infection 4/20/2015 11:02:46 AM
Eiger Biopharma Announces Senior Staff Appointments In Clinical Development And Regulatory Affairs: 4/14/2015 6:54:49 AM
Eiger Biopharma Announces Abstracts And Presentations Of Lonafarnib Data In Hepatitis Delta (HDV) At The European Association For The Study Of The Liver Conference - April 22 To 26, 2015 4/13/2015 7:30:22 AM
Eiger Biopharma Announces Presentation Of Positive Data In Patients Infected With Hepatitis Delta Virus (HDV) Treated With Lonafarnib 2/23/2015 6:51:38 AM
Eiger Biopharma Announces New HCV Synergy Data 7/1/2010 6:42:14 AM
Eiger Biopharma Announces Identification of a Novel Class of HCV Inhibitors 1/21/2010 9:24:20 AM
Eiger Biopharma Announces Initiation of CLEAN-1 HCV Phase 1b Trial 8/10/2009 8:26:41 AM
Eiger Biopharma Licenses Stanford University Hepatitis Technology 8/6/2009 7:32:09 AM
Eiger Biopharma Raises $7.1 Million 'A' Round Funding 2/24/2009 10:57:27 AM
12
//-->